Filtros de búsqueda

Lista de obras de

Does a mandatory non-medical switch from originator to biosimilar etanercept lead to increase in healthcare use and costs? A Danish register-based study of patients with inflammatory arthritis

scientific article published on 12 August 2019

Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): an observational nationwide study applying linkage between DANBIO and national registries

artículo científico publicado en 2020

How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers

artículo científico publicado en 2020

Malignant progression of precancerous lesions of the uterine cervix following biological DMARD therapy in patients with arthritis.

artículo científico publicado en 2015

One-year treatment outcomes of secukinumab versus tumor necrosis factor inhibitors in Spondyloarthritis

artículo científico publicado en 2020

Response to ''To switch or not to switch': the missing piece in the puzzle of biosimilar literature?' by Scherlinger et al

scientific article published on 23 January 2019

Risk of virus-associated cancer in female arthritis patients treated with biological DMARDs-a cohort study

artículo científico publicado en 2016

Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO reg

artículo científico publicado en 2021

Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritis

scientific article published on 23 October 2019

Waiting for JAK inhibitor safety data

artículo científico publicado en 2022

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda